Morning Briefing
Summaries of health policy coverage from major news organizations
Drug Industry Roundup: Fosamax Trial Focuses Scrutiny On Osteoporosis Drugs; What About $4 Generics; Recalls Undermining Confidence
Drugmakers face a slew of recalls and lawsuits; cheap generic drug prescriptions may skew health claims data
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
